Subscribe
Back to list

Jeff Giullian, MD

CMO

DaVita

Denver, CO

Dr. Giullian leads DaVita’s clinical strategy for kidney care, advancing quality, safety and value-based outcomes across the continuum of chronic kidney disease management. He has overseen the expansion of patient-centered tools like “Kidney Smart” and “DaVita Care Connect”, as well as the development of a tech-enabled chronic kidney disease EHR to support early diagnosis and treatment. Dr. Giullian’s leadership has driven a decline in hospitalizations and increased adoption of home dialysis, while also empowering physicians through the “OneView” platform and the Institute of Nephrology’s continuing medical education courses. He helped launch MedSleuth’s “BREEZE Transplant” platform to improve transplant readiness and co-led a national educational initiative with the American Diabetes Association. He is actively involved with the Renal Physicians Association and has supported curriculum development for first-generation healthcare students in Colorado.

Becker's Recognition

Jeff Giullian, MDhas been named a Becker's honoree on the lists below.

2025 Winner

Executives

Patient Safety Experts to Know

These Patient Safety Experts to Know have demonstrated exceptional dedication to enhancing patient care standards and minimizing healthcare risks. Their innovative approaches, extensive research, and commitment to safety protocols have significantly contributed to improving patient outcomes and setting new benchmarks in healthcare safety.

2026 Winner

Executives

145 Patient Safety Experts to Know

These Patient Safety Experts to Know have demonstrated exceptional dedication to enhancing patient care standards and minimizing healthcare risks. Their innovative approaches, extensive research, and commitment to safety protocols have significantly contributed to improving patient outcomes and setting new benchmarks in healthcare safety.

Newsletter

Join the 500,000+
healthcare executives
who start their day with
Becker’s

You can unsubscribe from these communications at any time. For more information, please review
our Privacy Policy.
More Newsletters